Apimeds Pharmaceuticals US Inc. Common Stock (APUS)
Stock · AMEX · Health Care
$3.87as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$18.9
Industry
Biotechnology: Pharmaceutical Preparations
About APUS
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Website
- www.apimedsus.com/
Fundamentals
- 1-day range
- $3.86$4.1
- Market cap
- $7.32M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-6.34
- Dividend yield
- —
- Beta
- 0.65
- Avg. volume
- 68.5K
52-week range
$3.39$403.1
Apimeds Pharmaceuticals US Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- APUSApimeds Pharmaceuticals US Inc. Common Stock$3.87▼ 1.28%Market cap $7.32MP/E —$3.39$403.1
- APREAprea Therapeutics Inc. Common stock$0.8387▼ 2.48%Market cap $7.40MP/E —$0.548$1.69
- TRAWTraws Pharma Inc. Common Stock$0.59▲ 0.00%Market cap $7.18MP/E —$0.4301$3.27
- PCSAProcessa Pharmaceuticals Inc. Common Stock$2.07▼ 1.90%Market cap $7.09MP/E —$1.67$14.24
- MTVAMetaVia Inc. Common Stock$1.71▲ 3.01%Market cap $7.64MP/E —$0.9661$19.03
- ADILAdial Pharmaceuticals Inc Common Stock$5.6▼ 1.41%Market cap $7.80MP/E —$1.31$249.81
- SNGXSoligenix Inc. Common Stock$0.38▲ 0.00%Market cap $8.22MP/E —$0.28$3.22
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| APUS Apimeds Pharmaceuticals US Inc. Common Stock | $7.32M | — | $3.87 | ▼ 1.28% | $3.39$403.1 |
| APRE Aprea Therapeutics Inc. Common stock | $7.40M | — | $0.8387 | ▼ 2.48% | $0.548$1.69 |
| TRAW Traws Pharma Inc. Common Stock | $7.18M | — | $0.59 | ▲ 0.00% | $0.4301$3.27 |
| PCSA Processa Pharmaceuticals Inc. Common Stock | $7.09M | — | $2.07 | ▼ 1.90% | $1.67$14.24 |
| MTVA MetaVia Inc. Common Stock | $7.64M | — | $1.71 | ▲ 3.01% | $0.9661$19.03 |
| ADIL Adial Pharmaceuticals Inc Common Stock | $7.80M | — | $5.6 | ▼ 1.41% | $1.31$249.81 |
| SNGX Soligenix Inc. Common Stock | $8.22M | — | $0.38 | ▲ 0.00% | $0.28$3.22 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · 8/27/2026
- Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On Aug 19, 2026; Freet Assigns All Apitox-Related Rights To Apimeds Pharmaceuticals; Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation For Apitoxbenzinga · 8/21/2026
- Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On Aug 19, 2026; Freet Assigns All Apitox-Related Rights To Apimeds Pharmaceuticals; Receives 100% Korean Clinic Rights, 25% U.S. Royalty, 25% Overseas Revenue Participation For ApitoxBenzinga · 8/21/2026
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 8/21/2026
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 8/18/2026
- Top movers in Tuesday's pre-market sessionChartMill · 8/18/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 8/18/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 8/17/2026
- These stocks are moving in today's pre-market sessionChartMill · 8/17/2026
See the full, filterable feed with live charts on the MarketWall dashboard.